Forget QE, Wall Street’ new drug is the stock buyback

By Wallace Witkowski

With the Federal Reserve’s quantitative-easing program out of the picture, share buybacks are now the preferred way to boost stock prices in the face of softening earnings. But like QE, it is unclear how long the buyback boom can last.”…

[Click HERE to read the full article]